It is important to note that the upregulation of COX-2 in early Alzheimer’s disease and the reduction of COX-2 in advanced Alzheimer’s disease correlate very well with the levels of prostaglandin E2 (PGE2) in cerebrospinal fluid (CSF). Here, PTGS2 is linked to early-onset autosomal dominant Alzheimer disease.